chrisvoncsefalvay/vaers-outcomes huggingface dataset:
11/13 around 7pm - felt tired.  Woke 11/14 at 5:45am hot, watery mouth, dizzy - started vomiting.  The dizziness would not stop - went to  Urgent Care.  They did not have means to do a CT scan so I was sent to the   ED.  Continued to feel dizzy and vomit.  A neurologist checked me and thought it may be vertigo.  Meniers was also mentioned.  ED wanted to keep me all night and do an MRI in the morning but neurologist did not think it was necessary.  I was discharged with instruction to see my PCP and ENT.  I went to a neuro PT on 11/15 and had a movement treatment.  It did seem to help but the dizziness continued just not as bad.  On 11/16 I left my PCP a voice mail asking what he thought about an MRI.  Return call 11/17 - he did not feel it was necessary.  On 11/8 had another treatment with PT - everything seem much better - no dizziness since 11/16, vomiting stopped 11/15.  Still feeling a little light headed but did return to work 11/17.  Still feeling fatigue.
Pt states that immediately after getting the vaccine she started having hot flashes. Pt was assisted in walking to the cot. Pt was seated on the cot. Pt's vitals are stable. Pt states she has a history of anxiety. Pt states she started lexapro 2 months ago. Pt continued to have hot flashes for 30 mins. Crew was able to calm the pt. Pt refused transport to hospital.
pt recvd vax 12APR93 & w/in minutes felt a pleuristy-type pain; pt had no shortness of breath nor any pulse or BP change; pain persisted throughout the evening & gradually dec in freq;
I61.9 - Intraparenchymal hemorrhage of brain (CMS/HCC) EXTREMITY WEAKNESS
got flushed, trying to "clear" throat, labored breathing, bp elevated, pulse 120's 15 minutes after vaccine administration. Given 50 mg of po benadryl and at the advice of her physician, 0.3mg epi im in R thigh. After epi, patient breathing slowed, flushing slowed, BP and pulse remained elevated. Pt. expressed feeling better. History of multiple allergies and seen in clinic. Encouraged by physician to receive vaccine.
Patient had received a Moderna vaccine on 5/14/2021 with no adverse events documented on patient. He then came to an event that was held and received a dose of Janssen vaccine
Body aches, joint pain, and sore muscle at site of injection All began upon waking the following day after injection
arm pain - patient was inadvertently given 0.3 mls of undiluted vaccine
Second dose administered in 18 days; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Second dose administered in 18 days) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002BQ1A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced OFF LABEL USE (Second dose administered in 18 days). On 12-Mar-2021, OFF LABEL USE (Second dose administered in 18 days) had resolved. Not Provided          No concomitant medications reported by reporter.  Treatment of these events were not provided.
Headache, NauseaVomiting & HYPERtension Narrative: Blood pressure elevated after 2nd dose to SPB in the 180-190's;also nausea and headache; went to primary care the following day for evaluation
just got the second shot/ first was Oct 2019; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: Age at vaccination was not reported. The patient received 1st dose of Shingrix in October 2019 and 2nd got just, which led to dose administration interval too long. The patient asked did he/she need a third dose.
Information has been received concerning a pt who on 05/24/96 was vaccinated with her first dose of varicella vaccine. The pt received the second dose of varicella on 07/18/96. It was noted that the pt was exposed to varicella and that there were no illnesses at the time of vaccination. On 06/13/2000 the pt experienced a fever of 101 F. She had muscle aches and approximately 15 pox. Unspecified medical attention was sought and the pt was diagnosed with varicella. Treatment included Tylenol as needed and rest. It was reported the pt recovered.
Pt to receive 2nd dose of Pfizer pediatric vaccine. Administrator pulled up 2.2 mL of diluent, and also pulled 0.2 mL of vaccine into syringe for a total dose of 2.4 mL dose. This amount was administered to the patient. This writer should have put the 2.2 mL of diluent into the medication vial to dilute all the medication. The patient should have received 0.2 mL of the diluted Pfizer vaccine, however received the full dose of diluent with the dose.
Pt is a resident at the facility. Facility's nurse reports she received a phone call at home from staff member on 10/21/02 at ~ 8:30pm reporting resident c/o tongue swelling and throat feeling like it was closing. He was given 50mg Benadryl and 911 was called. Transported to ER. Evaluated at ER and sent back to facility. Returned on 10/21/02 at 10:50pm. Distense summary showed he persisted Beandryl 50mg po at hospital. To continue Benadryl 50mg po q 6 hrs at facility.
Woke up with burning pain in both legs that was bothersome, but not horrible.  As the day went on the pain continued to increase.  I have only had nerve pain in my right leg with my CRPS so having pain in my left leg is completely unusual.  By the next day I was confined to my bed with pain in bilateral legs and arms.  Used narcotic pain pills which only brought down pain slightly.  Ended up spending 2 days confined to bed and the next few weeks in increased pain.  At the time of this reporting over 2 weeks has passed and pain is still not down to baseline level.
c/o swollen knee & ankle joints 2 days p/vax & 16OCT97 pt saw MD 29OCT for PSA test & sx reported to him;APPA PRN prescribed but not taken;
Fever, coughing, pharyngitis and vomiting x 2 days after immunization. Pt given TAMILFU on 12-11-09. Then went to ER on 12-12-09 2 Dx strep & received antibiotic shot.
UrticariaPruritus Narrative: injection site itching, progressively worsened: topical benadryl applied and symptoms abated
Presented with weakness/diarrhea/vomiting/fever/SOB; dx with Covid PNA; treated with Vit D/Vit C/Zinc/steroids/antibiotics; discharged home; No oxygen needed. pt died on 8/21/21 during subsequent admission (not covid related)
22APR95 730PM pt felt warm, temp not taken 930PM; t101 ax; 950PM pt started shaking, was unresponsive,stiffened lasting 2-3mins; taken to hosp per ambulance & was hospitalized x 12 hr for observation;
This report was originally received from a health professional in the on 12 March 2008. Follow-up information received on 27 March 2008 included additional unlisted event, and a narrative description was added at that time. A 49-year-old female patient, with a history of diabetes and sulfa allergy, received a subcutaneous left deltoid injection of YF-VAX (lot number UF139AA) on 03 March 2008. The patient had also received the following vaccines on 04 February 2008: a left deltoid intramuscular injection of ADACEL (lot number C2864AA), and a right deltoid intramuscular injection of HAVRIX (GlaxoSmithKline, lot number AHAVB195AB). Concomitant medications at the time of the event included LANTUS and HUMALOG. On 05 March 2008, she developed a "macular/papular/vesicular rash" on her extremities, with some additional lesions noted on the trunk. The rash was accompanied by dizziness, nausea, and malaise. The patient took one 25mg dose of BENADRYL for pruritis; no other treatment was noted. As of 12 March 2008, the patient reported a decreasing onset of new lesions, with a few vesicular lesions still noted. She denied egg allergy, recent diet changes, or febrile illness. No additional symptoms were noted. She was scheduled to follow-up with her physician.
Rash, swelling on entirety of body.  throat closing.  To ED visits, one the day after vaccination and the other 2 days after vaccination
Patient died at home. Most recent hospitalization at local Medical Center 09/13/21-09/16/21. Admit date 09/13/21 DX'd with respiratory distress, dyspnea, COVID, COPD exacerbation; HX of hypertension; allergies: doxycycline, sulfa drugs, Levaquin, tetracycline. HPI: COPD exacerbation, acute on chronic respiratory failure, encephalopathy, heart failure, paroxysmal atrial fibrillation, pacemaker, CKD stage 3, hypertension, GERD, Lumbar stenosis, gout, anxiety, osteoarthritis. Labs 09/14/21: bun 110mg/dl, creatinine 1.38mg/dl, calcium 11 mg/dl, magnesium  2.6mg/dl, bilil 1.3mg/dl, HGB 14.5g/dl, HCT 41.5 %, WBC 11.4K/ul. O2 sat 80% on room air; treated with solu-medrol 125 mg iv; self reported fever.
pt recvd vax;devel swelling & tenderness about size of "silver $" at inject site 3 days p/ vax;tx w/ Voltaren & Cytotec followed by Augmentin for 7 days;also recvd Ancef 2 g IV; recovered
Erythemais skin approximately 9 cm diameter to left buttock x2 days after KINRIX vaccine at this exam. No itching, systemic pruritus, raised borders or scaled skin appearance. Mtr noticed erythema x2 days after immunization.
First .25 ml influenza vaccine was given on 12/18/03.  Grandma states the client vomited but was ill one week prior.  After second .25ml dose the Mom reported vomiting, pale, heart racing, restless, and had bumps?? on face.
pt had numbness and redness in face on the left side. she left here feeling ok but got 1/2 hr down the road and stopped at a urgi-car center
Dose was 0.5mL. Next morning and all that day: dizziness, low grade fever, nausea, chills, headache and fatigue. Off and on the next 2 days then fine the 4th day (Tuesday 19th). At vaccine site in arm:  swelling, redness and itching intensely for 3 days, at a lower level days 4 and 5 (currently at day 5).
Crying, fussy 2-9 hours post immunization. Resolved 18 hours post vaccine.
At COVID Vaccination POD it 22 doses of Moderna Booster were drawn and administered from the vial. The patients names and demographic information is unknown due to the nature of the event. Please note DOB was required on this form and due to unknown status and requirement to complete form i was forced to enter todays date 11-19-2021 as date of birth.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; DRAINAGE ISSUES; This spontaneous report received from a patient concerned a 52 year male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-smoker, and non-alcoholic, and other pre-existing medical conditions included: The patient had no known allergies. The patient had no any drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose was not reported, 1 total, administered on 04-MAY-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 211D21A, expiry: unknown) dose was not reported, 1 total, administered on 19-JAN-2022 in right arm for prophylactic vaccination. Age at time of vaccination 52 years old. No concomitant medications were reported.  On 13-JUN-2022, the patient was not feeling well and had some drainage issues and itchy throat. On 14-JUN-2022 and 15-JUN-2022, he had a fever and did not felt well. On 16-JUN-2022 he did covid test and got result as he had covid. On 18-JUN-2022, the patient had head congestion. Thus patient had confirmed clinical vaccination failure and confirmed covid-19 infection. Patient reported that, he was still sick with covid (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of drainage issues and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint number: 90000236384.; Sender's Comments: V0: 20220638632- covid-19 vaccine ad26.cov2.s- confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Shot given on Friday, started to get sore Friday night, on Saturday it became pretty painful and by Sunday it was swollen, red, inflamed and itching from right shoulder to right wrist.  On Monday it began to subside and got better each day.  Today just slight redness in upper arm.
BLOOD CLOT; HEART ATTACK; This spontaneous report received from a consumer via a company representative via social media concerned a 59 year old male of unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The reporter stated that, "Second vax death in my family. My 33 year old brother died from a blood clot causing a stroke. 2 months after his 2nd pfz shot. Now my 59 year old uncle died from a blood clot causing a heart attack. 3 months after his only J&J shot. When will people realise that it's not safe?". It was unspecified if an autopsy was performed. On an unspecified date, the patient died from blood clot, and heart attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: 20211229627-Covid-19 vaccine ad26.cov2.s -Blood clot, heart attack. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: BLOOD CLOT; HEART ATTACK
On 11/20/07 mom called office to inform Dr. pt. had 4 1/2 x 4 1/2cm erythematosis, swollen, warm area.  Benadryl/warm compresses recommended.  On 11/21 pt. in to office with 11x11cm rash & erythemic area.  Tx with Omnicef 250mg po BID.  On 12/3/07 pt. in for follow up- resolved.
The patient received a dose that was beyond the 6 hour window that a reconstituted vial allows. A syringe was left in the fridge overnight and administered the following morning.
Patient (22 pounds, 7 oz; 31 inches) had his 12 month checkup on 28-AUG-2009 at 9:30am and received 4 vaccinations- MMRII, hep B, Prevnar and a varicella vaccine. He had no illness at the time of vaccination. Around 3pm he developed a mild fever and was very out of sorts. On 01-SEP-2009 when he awoke he had several red spots on his face and an eczema-like rash on his chest. He was still very out of sorts on 01-SEP-2009. Treatment included acetaminophen (CHILDREN'S TYLENOL) administered on 28-AUG-2009 and 01-SEP-2009. No medical attention was sought.
This spontaneous report as received from a Nurse practitioner refers to unspecified patients of unknown ages and genders. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On an unknown date, the patients were vaccinated with a dose of improperly stored GARDASIL 9 (which had a lot # of L013429 and an expiration date of 21-JUL-2017; however, dosage number and route of administration were not reported). Nevertheless, no adverse effects were reported. The vaccine experienced the following temperature excursions on an unspecified cumulative period of time since January 2016: 0.5 grades centigrade. Reportedly, there had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. Additional information has been requested.
approx 1mo ago (SEP95) pt recv vax & w/in 24 hr devel flu-like sx (achy, fever, nausea);
12/15/02 Achy, flu-like symptoms. 12/17/02 beginning of rash. 12/18/02 Red rash upper chest, back and arms; itchy.
issues with covid vaccine; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (issues with covid vaccine) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    The patient had no allergies.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced IMMUNISATION REACTION (issues with covid vaccine). At the time of the report, IMMUNISATION REACTION (issues with covid vaccine) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.   The reporter causality for the events of issues with covid vaccine with Humira(adalimumab) was no reasonable possibility.  No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked in.
Breakthrough case admission after 5 vaccines Pfizer 1/30/21 lot# EL9265;  Pfizer 2/20/21 lot# EN6201;  Pfizer 9/29/21 lot# FF2589;  4/5/22 Moderna lot# 048L21A;  Moderna 9/20/22 lot# AS7162B
Swelling, redness, and itching on injection site. Tonsils were swollen which made swallowing very painful.
Patient arrived in office 3 hrs after getting vaccination with hives on face, arms, back and stomach.. Patient was also stung by a wasp prior to arrival. We are unclear what caused the reaction.
9/6/07 Fever 105.1, thick green mucous suctioned from airway. O2 sat at 78-88, Albuterol neb and O2 given. Sent to ED and pt admitted to hospital. Treated with antibiotic for viral vs atypical pneumonia. Discharged from hospital 9-7-07 in stable condition.   11/13/2007 MR received for DOS 9/6/2007. Pt presented to ER with fever (105'F) and hypoxia. O2 sats at nsg facility dropped to 78-88%.  Suctioned for "grren stuff".  O2 sats in ER mid 90's on RA. Txd with abx
I had severe neck pain.  I called my doctor who called me back and told me to go to the emergency room.  The emergency room then admitted me to the hospital.  The tests they did were Lumbar Spinal Puncture, an MRI, CT Scan, and a PET Scan.  They determined but not with 100% accuracy that I have C1 & C2 Dins Area Metastatic Cancer but can't confirm without biopsy but unable to do due to the location.
psoriasis spread all over body and patient was really covered with it; This is a spontaneous report from a contactable consumer reported for himself. An 87-year-old male patient received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. Medical history included psoriasis on his legs, had reactions to medications (doesn't specify which ones) in the past that have resulted in sleeping problems, stress and heightened blood pressure. The patient's concomitant medications were not reported. Patient had his first dose of the vaccine on 09Jan2021. He has psoriasis on his legs at baseline but reports that a few days after the vaccine the psoriasis spread all over body and patient was really covered with it. Patient was working with a dermatologist. The event outcome was unknown.   Information about batch/lot number has been requested.
Hives; Very itchy; Arm hurt a bit; Looked like she had measles; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), PRURITUS (Very itchy), PAIN IN EXTREMITY (Arm hurt a bit) and RASH MORBILLIFORM (Looked like she had measles) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included UTI and Surgery (She had emergency surgery from an UTI and blood transfusion as she was internally bleeding.).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced URTICARIA (Hives), PRURITUS (Very itchy), PAIN IN EXTREMITY (Arm hurt a bit) and RASH MORBILLIFORM (Looked like she had measles). At the time of the report, URTICARIA (Hives), PRURITUS (Very itchy), PAIN IN EXTREMITY (Arm hurt a bit) and RASH MORBILLIFORM (Looked like she had measles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
EXTREME/EXCRUCIATING PAIN; SLEEPING 20 HOURS A DAY; EXTREME TIREDNESS; This spontaneous report received from a patient concerned a 47 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included psoriatic arthritis, and spondylosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: Unknown) dose was not reported, administered on 20-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 20-MAR-2021, the subject experienced extreme/excruciating pain. On 20-MAR-2021, the subject experienced sleeping 20 hours a day. On 20-MAR-2021, the subject experienced extreme tiredness. Treatment medications (dates unspecified) included: alprazolam, and hydrocodone bitartrate/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extreme/excruciating pain on 20-MAR-2021, had not recovered from extreme tiredness, and the outcome of sleeping 20 hours a day was not reported. This report was non-serious.
1 day after immunizations were given, parents noticed patient's left upper arm was red, swollen, and itchy.  On exam 2 days after immunization, she has erythema, induration, and swelling extending from her left shoulder to about 4 cm from her elbow.  The arm is warm to touch but not tender.
Moderna COVID-19 Vaccine EUA Left arm, extreme injection site pain, pain & stiff left shoulder & neck; pain in upper left of mouth, some pain blinking left eye, intermittent dull/sharp pains left side of head, 11/2-11/6/2021. Intermittent pain & stiffness over next months. Pinky & 4th fingers, left hand tingling + more pain left arm up to left side of head started 12/24/2021 - intermittently is on-going..  some days are awful while other days are better.
Fever up to 101.9, chills, muscle ache, lasted roughly 35 hours